|
39
|
191
|
5hmaA |
Crystal structure of mamo protease domain from magnetospirillum magneticum (ni bound form) |
|
14
|
99
|
5hizA |
The structure of pedv nsp9 |
|
59
|
254
|
4zxyH |
Factor viia in complex with the inhibitor (2r)-2-[(1-aminoisoquinolin-6-yl)amino]-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione |
|
52
|
223
|
5gibA |
Succinic acid bound trypsin crystallized as dimer |
|
57
|
259
|
5gdsH |
Hirunorms are true hirudin mimetics. the crystal structure of human alpha-thrombin:hirunorm v complex |
|
15
|
95
|
5gchG |
Chemistry of caged enzymes /ii$. photoactivation of inhibited chymotrypsin |
|
42
|
180
|
5fx6A |
Novel inhibitors of human rhinovirus 3c protease |
|
23
|
154
|
5gpiB |
Crystal structures of unlinked ns2b-ns3 protease from zika virus and its complex with a reverse peptide inhibitor |
|
56
|
223
|
5fxlA |
Structure of trypsin solved by mr from data collected by direct data collection (ddc) using the esrf robodiff goniometer |
|
28
|
153
|
5gj4B |
Structure of ns2b-ns3 protease from zika virus caught after self-cleavage |
|
43
|
180
|
5fx5A |
Novel inhibitors of human rhinovirus 3c protease |
|
68
|
335
|
5gndA |
Structure of deg protease hhoa from synechocystis sp. pcc 6803 |
|
15
|
131
|
5gchF |
Chemistry of caged enzymes /ii$. photoactivation of inhibited chymotrypsin |
|
31
|
152
|
5g4bA |
Crystal structure of aura virus capsid protein in complex with piperazine. |
|
202
|
645
|
5fpyA |
Structure of hepatitis c virus (hcv) full-length ns3 complex with small-molecule ligand 5-bromo-1-methyl-1h-indole-2-carboxylic acid (at21457) in an alternate binding site. |
|
60
|
228
|
5fbeA |
Complement factor d in complex with compound2 |
|
64
|
240
|
5avdA |
The 0.86 angstrom structure of elastase crystallized in high-strength agarose hydrogel |
|
110
|
470
|
5fl7D |
Structure of the f1c10 complex from yarrowia lipolytica atp synthase |
|
55
|
234
|
4z0kA |
Rapid development of two factor ixa inhibitors from hit to lead |
|
53
|
239
|
5f8tA |
The crystal structure of human plasma kallikrein in complex with its peptide inhibitor pkalin-2 |
|
82
|
319
|
5fhtA |
Htra2 protease mutant v226k |
|
54
|
239
|
5f8zA |
The crystal structure of human plasma kallikrein in complex with its peptide inhibitor pkalin-1 |
|
199
|
645
|
5fptA |
Structure of hepatitis c virus (hcv) full-length ns3 complex with small-molecule ligand 2-(1-methyl-1h-indol-3-yl)acetic acid (at3437) in an alternate binding site. |
|
84
|
298
|
4zuhA |
Complex structure of pedv 3clpro mutant (c144a) with a peptide substrate. |
|
245
|
728
|
5ejzA |
Bacterial cellulose synthase product-bound state |
|
58
|
230
|
5fcrA |
Mouse complement factor d |
|
13
|
84
|
5f53A |
Nano-ring of cadmium ions coordinated by nvpizza2-s16s58 |
|
61
|
228
|
5fbiA |
Complement factor d in complex with compound 3b |
|
55
|
239
|
5f8xA |
The crystal structure of human plasma kallikrein in complex with its peptide inhibitor pkalin-3 |
|
202
|
645
|
5fpsA |
Structure of hepatitis c virus (hcv) full-length ns3 complex with small-molecule ligand 3-aminobenzene-1,2-dicarboxylic acid (at1246) in an alternate binding site. |
|
91
|
306
|
4yoiA |
Structure of hku4 3clpro bound to non-covalent inhibitor 1a |
|
150
|
604
|
5eokA |
Human plasma coagulation factor xi in complex with peptide p39 |
|
45
|
192
|
5eqsA |
Crystal structure of a genotype 1a/3a chimeric hcv ns3/4a protease in complex with asunaprevir |
|
55
|
223
|
5eg4A |
Bovine trypsin in complex with cyclic inhibitor |
|
49
|
238
|
5e2oA |
Factor xia in complex with the inhibitor 4-[(n-{(2e)-3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoyl}-l-phenylalanyl)amino]benzoic acid |
|
53
|
237
|
5exnA |
Factor xia (c500s [c122s]) in complex with the inhibitor methyl ~{n}-[4-[2-[(1~{s})-1-[[(~{e})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-2-phenyl-ethyl]pyridin-4-yl]phenyl]carbamate |
|
52
|
234
|
4zaeA |
Development of a novel class of potent and selective fixa inhibitors |
|
46
|
198
|
5eqrA |
Crystal structure of a genotype 1a/3a chimeric hcv ns3/4a protease in complex with danoprevir |
|
48
|
238
|
5ejlA |
Mrkh, a novel c-di-gmp dependence transcription regulatory factor. |
|
49
|
238
|
5e2pA |
Factor xia in complex with the inhibitor n-[(1s)-1-benzyl-2-[2-[5-chloro-2-(tetrazol-1-yl)phenyl]ethylamino]-2-oxo-ethyl]-4-hydroxy-2-oxo-1h-quinoline-6-carboxamide |
|
156
|
604
|
5eodA |
Human plasma coagulation fxi with peptide lp2 |
|
51
|
238
|
5exlA |
Factor xia in complex with the inhibitor 4-(aminomethyl)-~{n}-[(1~{s})-1-[4-(3-oxidanyl-1~{h}-indazol-5-yl)pyridin-2-yl]-2-phenyl-ethyl]cyclohexane-1-carboxamide |
|
42
|
191
|
5etxA |
Crystal structure of hcv ns3/4a protease a156t variant in complex with 5172-linear (mk-5172 linear analogue) |
|
46
|
190
|
5eqqA |
Crystal structure of hcv ns3/4a wt protease in complex with 5172-linear (mk-5172 linear analogue) |
|
85
|
299
|
4zroA |
2.1 a x-ray structure of fipv-3clpro bound to covalent inhibitor |
|
52
|
238
|
5exmA |
Factor xia in complex with the inhibitor methyl ~{n}-[4-[2-[(1~{s})-1-[[4-(aminomethyl)cyclohexyl]carbonylamino]-2-phenyl-ethyl]pyridin-4-yl]phenyl]carbamate |
|
46
|
197
|
5epnA |
Crystal structure of hcv ns3/4a protease in complex with 5172-mcp1p3 (mk-5172 p1-p3 macrocyclic analogue) |
|
46
|
198
|
5epyA |
Crystal structure of hcv ns3/4a protease a156t variant in complex with 5172-mcp1p3 (mk-5172 p1-p3 macrocyclic analogue) |
|
91
|
306
|
4yogA |
Hku4-3clpro bound to non-covalent inhibitor 3b |
|
39
|
174
|
5e0hA |
1.95 a resolution structure of norovirus 3cl protease in complex with a triazole-based macrocyclic (18-mer) inhibitor |
